Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Corcept’s flagship drug recovers from FDA snub with different approval from Rifiorri for ovarian cancer
Following a new U.S. green light for some ovarian cancer patients, Corcept Therapeutics has redeemed…
Ionis Pharmaceuticals is slashing the price of its expected blockbuster drug, Tringolza (olesarsen), in preparation…
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for inherited lysosomal storage diseases, breaking…
In the past seven months, Boehringer Ingelheim has won approval and label extensions in the…
South Korea’s Arteogen ensnared another big pharma partner, Biogen, after luring GSK, which topped this…
Takeda Pharmaceutical is preparing for a new radical restructuring aimed at streamlining operations to fund…
Karyopharm’s Expovio has stalled in the clinic and market after gaining approval for the treatment…
Despite recent policy uncertainties, Wuxi Biologics’ focus on its US operations will continue to pay…
Eli Lilly is scaling back the rollout of its traditional insulin in Europe, with plans…
A high-profile drug fraud case that could potentially throw the pharmaceutical industry into the legal…